Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu
Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu Detail:
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Name | triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane |
Synonyms | 2-(triphenyl-phosphanylidene)-propionic acid ethyl ester |
CAS Number | 21382-82-1 |
CAT Number | RF-PI179 |
Stock Status | In Stock, Production Scale Up to Tons |
Molecular Formula | C23H23O2P |
Molecular Weight | 362.41 |
Brand | Ruifu Chemical |
Item | Specifications |
Appearance | Yellow Powder |
Purity / Analysis Method | ≥98.0% (HPLC) |
Loss on Drying | ≤1.0% (60℃, 2h) |
Sum of PH3P+PH3PO | ≤2.0% (HPLC) |
Unspecified Related Substance | ≤0.5% (HPLC) |
Test Standard | Enterprise Standard |
Usage | Intermediate of Sofosbuvir (CAS: 1190307-88-0) |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Manufacturer with High Purity and Stable Quality
Commercial Supply Sofosbuvir (CAS: 1190307-88-0) and Related Intermediates:
Sofosbuvir CAS: 1190307-88-0
N4-Benzoylcytosine CAS: 26661-13-2
triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS: 21382-82-1
Pentafluorophenol CAS: 771-61-9
N-[(S)-(2,3,4,5,6-pentafluorophenoxy)phenoxyphosphinyl]-L-alanine 1-Methylethyl ester CAS: 1334513-02-8
Sofosbuvir is a drug used for the treatment of hepatitis C. It is recommended to be used in combination with other drugs (such as velpatasvir) for the first-line treatment for HCV genotypes 1, 2, 3, 4, 5, and 6. It takes effect through acting as a nucleotide analog inhibitor, being capable of specially inhibiting the HCV NS5B (non-structural protein 5B) RNA-dependent RNA polymerase. Oral sofosbuvir was generally well tolerated in patients with chronic hepatitis C. The most commonly reported adverse events and laboratory abnormalities in patients receiving sofosbuvir plus ribavirin with or without peginterferon-alpha were consistent with those expected in patients receiving treatment with ribavirin and peginterferon-alpha, and co-administering sofosbuvir did not appear to increase the frequency or severity of these adverse events or laboratory abnormalities.
Product detail pictures:
Related Product Guide:
Our mission will be to become an innovative supplier of high-tech digital and communication devices by furnishing benefit added structure, world-class manufacturing, and service capabilities for Short Lead Time for 2-(4-Nitrophenyl)ethylamine Hydrochloride - triphenyl(1-[ethoxycarbonyl]ethylidene)phosphorane CAS 21382-82-1 Sofosbuvir Intermediate High Purity – Ruifu , The product will supply to all over the world, such as: Kuwait, Boston, California, We are confident that we are able to provide you with opportunities and will be a valuable business partner of you. We look forward to working with you soon. Learn more about the types of products that we work with or contact us now directly with your inquiries. You are welcome to contact us anytime!
By Mary from Mumbai - 2017.04.28 15:45
This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
By Moira from Bangladesh - 2017.05.02 11:33